CLEMENT ALUYI: Open Payments
NPI 1447459607 · PULASKI, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,879 in 91 payments from 30 companies in 2025. Trend: 2023 $2,380 · 2024 $1,702 · 2025 $1,879
Food & beverage: $1,880
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $359 |
| AstraZeneca Pharmaceuticals LP | 8 | $212 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $211 |
| Aimmune Therapeutics, Inc. | 4 | $92 |
| E.R. Squibb & Sons, L.L.C. | 4 | $89 |
| Axsome Therapeutics, Inc. | 4 | $77 |
| Lundbeck LLC | 3 | $74 |
| Vanda Pharmaceuticals Inc. | 3 | $72 |
| PFIZER INC. | 4 | $70 |
| GlaxoSmithKline, LLC. | 3 | $64 |
Products named: CAPLYTA, VRAYLAR, REXULTI, MAVYRET, AIRSUPRA, ZENPEP, HETLIOZ, COBENFY.
Industry payments across TN — which companies pay providers there.
